Literature DB >> 8498842

Reduction of low-molecular-weight acid phosphatase activity in Alzheimer brains.

S Shimohama1, S Fujimoto, T Taniguchi, M Kameyama, J Kimura.   

Abstract

Recent studies in Alzheimer brains have shown aberrant protein phosphorylation, suggesting an alteration in protein kinases and/or phosphoprotein phosphatases. In the present study, the activity of acid phosphatase was investigated in samples prepared from postmortem normal human and Alzheimer brains. p-Nitrophenyl phosphate, a nonprotein phosphoester, was used as a substrate for acid phosphatase. The separation profile on Sephadex G-100 gel filtration chromatography revealed that two major forms of high-molecular-weight and low-molecular-weight acid phosphatase were present in the crude extracts of both rat and human brains. Another class of zinc ion (Zn2+)-dependent acid p-nitrophenyl phosphatase was also detected in rat and human brains. In Alzheimer brains, the low-molecular-weight acid phosphatase activity was significantly decreased compared to that in control brains; however, the high-molecular-weight and Zn(2+)-dependent acid phosphatase activity in control and Alzheimer brains was not different. These results suggest that reduced activity of the low-molecular-weight acid phosphatase, which possesses phosphotyrosine protein phosphatase activity, might be linked to aberrant protein tyrosine phosphorylation found in Alzheimer brains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498842     DOI: 10.1002/ana.410330610

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Receptor-mediated regulation by histamine of the acid phosphatase activity in cultured cerebral endothelial cells.

Authors:  C A Szabó; I Krizbai; M A Deli; C S Abrahám; F Joó
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

Review 2.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 3.  Cognitive enhancement therapy for Alzheimer's disease. The way forward.

Authors:  L Parnetti; U Senin; P Mecocci
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 4.  Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.

Authors:  L W Jin; T Saitoh
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 5.  Voltage sensitive phosphatases: emerging kinship to protein tyrosine phosphatases from structure-function research.

Authors:  Kirstin Hobiger; Thomas Friedrich
Journal:  Front Pharmacol       Date:  2015-01-10       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.